Eric Wayne Golightly

Array ( [id] => 6797774 [patent_doc_number] => 20030176648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Ion channel' [patent_app_type] => new [patent_app_number] => 10/202824 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18399 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176648.pdf [firstpage_image] =>[orig_patent_app_number] => 10202824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870797 [patent_doc_number] => 20030083487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Progestogen receptor polypeptides, transgenic cells in which genes encoding said polypeptides are introduced and method for detecting disruptors for progestogens by using said transgenic cells' [patent_app_type] => new [patent_app_number] => 10/202846 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4805 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083487.pdf [firstpage_image] =>[orig_patent_app_number] => 10202846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 902688 [patent_doc_number] => 07335481 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => 'Methods of identifying compounds that affect a fatty acid cell-surface receptor' [patent_app_type] => utility [patent_app_number] => 10/202687 [patent_app_country] => US [patent_app_date] => 2002-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11354 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335481.pdf [firstpage_image] =>[orig_patent_app_number] => 10202687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7358790 [patent_doc_number] => 20040014149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein' [patent_app_type] => new [patent_app_number] => 10/197962 [patent_app_country] => US [patent_app_date] => 2002-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 31270 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014149.pdf [firstpage_image] =>[orig_patent_app_number] => 10197962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6735504 [patent_doc_number] => 20030013139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Transgenic cells and a method for detecting disruptors for androgens by using said transgenic cells' [patent_app_type] => new [patent_app_number] => 10/175822 [patent_app_country] => US [patent_app_date] => 2002-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3220 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013139.pdf [firstpage_image] =>[orig_patent_app_number] => 10175822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6467555 [patent_doc_number] => 20020150989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Human tumor necrosis factor receptor' [patent_app_type] => new [patent_app_number] => 10/164592 [patent_app_country] => US [patent_app_date] => 2002-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12949 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20020150989.pdf [firstpage_image] =>[orig_patent_app_number] => 10164592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6804942 [patent_doc_number] => 20030232336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Novel human ion channel and transporter family members' [patent_app_type] => new [patent_app_number] => 10/162102 [patent_app_country] => US [patent_app_date] => 2002-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 329670 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232336.pdf [firstpage_image] =>[orig_patent_app_number] => 10162102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846930 [patent_doc_number] => 20030166097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Human tumor necrosis factor receptor' [patent_app_type] => new [patent_app_number] => 10/155167 [patent_app_country] => US [patent_app_date] => 2002-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12923 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166097.pdf [firstpage_image] =>[orig_patent_app_number] => 10155167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 830049 [patent_doc_number] => 07399602 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-15 [patent_title] => 'Method of prognosticating respiratory bacterial infection using urokinse receptor measurement' [patent_app_type] => utility [patent_app_number] => 10/478331 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13892 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399602.pdf [firstpage_image] =>[orig_patent_app_number] => 10478331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801183 [patent_doc_number] => 20030096348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'DNA molecules encoding mammalian nuclear receptor protein, nNR5' [patent_app_type] => new [patent_app_number] => 10/151542 [patent_app_country] => US [patent_app_date] => 2002-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16513 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096348.pdf [firstpage_image] =>[orig_patent_app_number] => 10151542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5845278 [patent_doc_number] => 20020132775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Human potassium channel 1 and 2 proteins' [patent_app_type] => new [patent_app_number] => 10/143002 [patent_app_country] => US [patent_app_date] => 2002-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12862 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132775.pdf [firstpage_image] =>[orig_patent_app_number] => 10143002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844391 [patent_doc_number] => 20020132331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Human DNA Ligase IV' [patent_app_type] => new [patent_app_number] => 10/141132 [patent_app_country] => US [patent_app_date] => 2002-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11510 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132331.pdf [firstpage_image] =>[orig_patent_app_number] => 10141132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 334131 [patent_doc_number] => 07507542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Method for regulating immune function using the FOXP3 protein' [patent_app_type] => utility [patent_app_number] => 10/142667 [patent_app_country] => US [patent_app_date] => 2002-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 29 [patent_no_of_words] => 39198 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507542.pdf [firstpage_image] =>[orig_patent_app_number] => 10142667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761147 [patent_doc_number] => 20030124508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Method for testing the hormonal effect of substances' [patent_app_type] => new [patent_app_number] => 10/137418 [patent_app_country] => US [patent_app_date] => 2002-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6102 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124508.pdf [firstpage_image] =>[orig_patent_app_number] => 10137418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 707381 [patent_doc_number] => 07060463 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'DNA molecules encoding Macaca mulatta androgen receptor' [patent_app_type] => utility [patent_app_number] => 10/476724 [patent_app_country] => US [patent_app_date] => 2002-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13252 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060463.pdf [firstpage_image] =>[orig_patent_app_number] => 10476724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 728159 [patent_doc_number] => 07041496 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-09 [patent_title] => 'DNA encoding rodent KCNQ2 potassium channel' [patent_app_type] => utility [patent_app_number] => 10/128870 [patent_app_country] => US [patent_app_date] => 2002-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 63 [patent_no_of_words] => 12332 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041496.pdf [firstpage_image] =>[orig_patent_app_number] => 10128870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 436032 [patent_doc_number] => 07262289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-28 [patent_title] => 'KCNQ potassium channels and methods of modulating same' [patent_app_type] => utility [patent_app_number] => 10/131685 [patent_app_country] => US [patent_app_date] => 2002-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 63 [patent_no_of_words] => 12337 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/262/07262289.pdf [firstpage_image] =>[orig_patent_app_number] => 10131685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1014803 [patent_doc_number] => 06894147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-17 [patent_title] => 'Intermediate conductance calcium-activated potassium channels (IK1)' [patent_app_type] => utility [patent_app_number] => 10/115695 [patent_app_country] => US [patent_app_date] => 2002-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32995 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/894/06894147.pdf [firstpage_image] =>[orig_patent_app_number] => 10115695 [rel_patent_id] =>[rel_patent_doc_number] =>)